MSCs were preferentially recruited into fractured bones from progenitor niches near fracture sites. + mSSCs purified from fractured bones were stable for at least 3 weeks in culture, expressed common MSC markers, and differentiated into osteoblasts in fracture sites. Fig. S4 . Effects of COX-2 signaling blockade on the osteogenic potential of CD90 + mSSCs. Fig. S5 . COX-2 overexpression in fracture sites augmented local expression of WNT ligands. Fig. S6 . Local COX-2 overexpression reduced callus sizes, and this effect was abolished by the administration of the anti-CD90 mAb 30H12 (see Fig. 6 for details of experimental designs). Fig. S7 . A model for COX-2 overexpression-mediated acceleration of bone repair. Fig. S8 . Delivery of vectors into fracture sites.
This PDF file includes: Table S1 . Primers used in this study. Where applicable, data are means ± SEM. *P<0.05, **P<0.01, ****P<0.0001. N=(3-5). Data are presented as mean ± SEM. **P<0.01, ****P<0.0001. N=5. A representative image shows vector delivery into a fractured tibia.
